Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients
Open Access
- 7 December 2004
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 128 (1), 42-48
- https://doi.org/10.1111/j.1365-2141.2004.05280.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Allogeneic hematopoietic stem cell transplantation for myelofibrosisBlood, 2003
- Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in miceBlood, 2002
- Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemiaEuropean Journal of Haematology, 2002
- Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasiaBlood, 2001
- Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryoThe EMBO Journal, 2000
- The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid MetaplasiaBritish Journal of Haematology, 1999
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- Identification of ‘short‐lived’ and ‘long‐lived’ patients at presentation of idiopathic myelofibrosisBritish Journal of Haematology, 1997
- Circulating pluripotent haemopoietic cells in patients with myeloproliferative disordersBritish Journal of Haematology, 1983
- Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasiaAmerican Journal of Hematology, 1978